Phase II Study With Oxaliplatin In Children With Relapsed/Refractory Solid Tumors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Oxaliplatin (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 26 Mar 2013 Biomarkers information updated
- 25 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Mar 2012 New trial record